AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIOGEN INC. Director's Dealing 2020

Sep 28, 2020

30291_dirs_2020-09-28_0a6a0579-eb40-44c7-a1a9-7e6883558e58.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Denali Therapeutics Inc. (DNLI)
CIK: 0001714899
Period of Report: 2020-09-22

Reporting Person: BIOGEN INC. (10% Owner)
Reporting Person: Biogen MA Inc. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13310243	Indirect

Footnotes

F1: Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc.